| Literature DB >> 35903265 |
Chen Chen1, Yu Gao2, Demei Zhao2, Zhouji Ma2, Yunyan Su3, Ran Mo2.
Abstract
Background: One of the most drastic complications of median sternal incision is deep sternal wound infection (DSWI), as it can lead to prolonged hospitalization, increased expected costs, re-entry into the ICU and even reoperation. Since the pectoralis major muscle flap (PMMF) technique was proposed in the 1980s, it has been widely used for sternal reconstruction after debridement. Although numerous studies on DSWI have been conducted over the years, the literature on DSWI in Chinese population remains limited. The purpose of this study was to investigate the clinical characteristics of DSWI in patients and the clinical effect of the PMMF at our institution.Entities:
Keywords: DSWI; PMMF; cardiac surgery; flap; infection
Year: 2022 PMID: 35903265 PMCID: PMC9314736 DOI: 10.3389/fsurg.2022.870044
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Flowchart of patient selection algorithm based on inclusion and exclusion criteria. DSWI, deep sternal wound infection. PMMF, pectoralis major muscle flap.
Figure 2Appearance of deep sternal wound infection before operation.
Figure 3Surgical procedure and postoperative photos. (A) Infected sternum and implants (blue circle) were removed; (B) The left pectoralis major muscle was exposed; (C) Complete exposure of the pectoralis major muscle (blue circle) and overturning to cover the wound; (D) Suturing through the muscle flap; (F) Immediate appearance after operation; (G) Appearance 2 years after operation.
Clinical features of DSWI group and control group.
| Variables | DSWI group ( | Control group ( | |
|---|---|---|---|
| Age(y) | 57.1 ± 17.1 | 51.4 ± 34.7 | <0.01 |
| Gender(man) | 74(55.2%) | 5187(53.5%) | 0.68 |
| Diabetes | 23(17.2%) | 742(7.7%) | <0.01 |
| Hypertension | 39(29.1%) | 2215(22.9%) | 0.09 |
| BMI (kg/m2) | 24.9 ± 4.1 | 22.9 ± 4.3 | <0.01 |
| Isolated CABG procedure | 32(23.9%) | 1547(16.0%) | <0.01 |
| Isolated Valve procedure | 45(33.6%) | 3742(38.6%) | 0.23 |
| CABG + Valve procedure | 18(13.4%) | 726(7.5%) | 0.01 |
| Aortic procedure | 18(13.4%) | 1922(19.8%) | 0.06 |
| Others | 21(15.7%) | 1753(18.1%) | 0.47 |
| CPB time(min) | 180.1 ± 20.2 | 161 ± 27.3 | <0.01 |
| Transfusion | 59(44.0%) | 3754(38.7%) | 0.21 |
| Repeat sternotomy | 17(12.7%) | 271(2.8%) | <0.01 |
DSWI, deep sternal wound infection; CABG, coronary artery bypass grafting; BMI, body mass index; CPB, cardiopulmonary bypass.
Multivariate conditional logistic regression results for deep sternal wound infection (DSWI).
| Variables | Odds Ratio | 95% confidence interval | |
|---|---|---|---|
| Age | 0.81 | 0.99 | 0.98–1.02 |
| BMI | 0.02 | 1.08 | 1.01–1.16 |
| Isolated CABG | 0.38 | 2.51 | 0.32–19.41 |
| CABG + Valveprocedure | 0.08 | 1.89 | 0.92–3.87 |
| CPB time | 0.06 | 1.01 | 1.00–1.07 |
| Transfusion | 0.24 | 1.35 | 0.82–2.20 |
| Repeat sternotomy | <0.01 | 5.93 | 2.88–12.25 |
CABG, coronary artery bypass grafting; BMI, body mass index; CPB, cardiopulmonary bypass.
Demographics and operative variables of eligible patients.
| Variables | PMMF group ( | Non-PMMF group ( | |
|---|---|---|---|
| Age(y) | 55.3 ± 16.5 | 57.5 ± 17.4 | 0.54 |
| Gender(man) | 16(51.6%) | 58(56.3%) | 0.65 |
| Diabetes | 5(16.1%) | 18(15.5%) | 0.86 |
| Hypertension | 7(22.6%) | 32(31.1%) | 0.36 |
| BMI (kg/m2) | 24.5 ± 4.1 | 25.1 ± 4.3 | 0.46 |
| Isolated CABG procedure | 6(19.4%) | 26(25.5%) | <0.01 |
| Isolated Valve Procedure | 15(48.4%) | 30(29.1%) | 0.04 |
| CABG + Valve procedure | 3(9.7%) | 15(14.6%) | 0.48 |
| Aortic procedure | 6(19.4%) | 12(11.7%) | 0.27 |
| Others | 1(3.2%) | 20(19.4%) | 0.03 |
| CPB time(min) | 183.9 ± 21.3 | 177.5 ± 19.7 | 0.12 |
| Transfusion | 10(32.3%) | 49(47.6%) | 0.13 |
| Repeat ternotomy | 9(29.0%) | 8(7.8%) | <0.01 |
CABG, coronary artery bypass grafting; BMI, body mass index; CPB, cardiopulmonary bypass; PMMF, pectoralis major muscle flap.
Pathogenic data of the DSWI patient.
| Etiology | Patients with a diagnosis of etiology [ | |
|---|---|---|
| PMMF group ( | Non-PMMF group ( | |
| GNB | 10(32.3%) | 32(31.1%) |
| Pseudomonas aeruginosa | 2(6.5%) | 12(11.7%) |
| Acinetobacter baumannii | 8(25.8%) | 17(16.5%) |
| Enterobacter cloacae | 0(0.0%) | 3(2.9%) |
| GPC | 12(38.7%) | 43(41.7%) |
| Staphylococcus aureus | 9(29.0%) | 24(23.3%) |
| MRSA | 2(6.5%) | 10(9.7%) |
| Enterococcus faecalis | 1(3.2%) | 9(8.7%) |
| Mixed infection | 9(29.0%) | 28(27.2%) |
GNB, gram negative bacteria; GPC, gram positive bacteria; MRSA, Methicillin resistant Staphylococcus aureus.
Results of operation in two groups.
| Characteristics | PMMF group ( | Non-PMMF group ( | |
|---|---|---|---|
| Time to extubation, h | 6.7 ± 3.8 | 20.4 ± 26.8 | <0.001 |
| ICU time, d | 1.7 ± 1.7 | 7.5 ± 8.5 | <0.001 |
| 24-hour drainage,ml | 450.0 ± 528.5 | 708.9 ± 674.8 | 0.210 |
| Hospitalization time, d | 29.9 ± 29.9 | 49.2 ± 34.2 | <0.001 |
| Postoperative hospitalization time, d | 21.4 ± 17.1 | 41.9 ± 28.6 | <0.001 |
| Survival rate | 30 (96.8%) | 82(79.6%) | 0.026 |
ICU, intensive care unit; PMMF, pectoralis major muscle flap; h, hours; d, days.
Figure 4Comparison of survival rates between the PMMF group and the control group. PMMF, pectoralis major muscle flap. *: P < 0.05.
Multivariate conditional logistic regression results for survival rate after operation.
| Variables | Odds Ratio | 95% confidence interval | |
|---|---|---|---|
| Age | 0.91 | 0.99 | 0.97–1.03 |
| BMI | 0.86 | 1.01 | 0.90–1.13 |
| PMMF | 0.04 | 0.12 | 0.01–0.90 |
| Isolated CABG | 0.33 | 2.51 | 0.32–19.41 |
| Isolated valve procedure | 0.41 | 1.78 | 0.46–6.93 |
| CABG + Valve procedure | 0.16 | 4.88 | 0.54–44.37 |
| Aortic procedure | 0.40 | 0.54 | 0.13–2.28 |
| Others | 0.97 | 1.02 | 0.21–5.08 |
| CPB time | 0.68 | 0.99 | 0.97–1.02 |
CABG, coronary artery bypass grafting; BMI, body mass index; CPB, cardiopulmonary bypass; PMMF, pectoralis major muscle flap.